Reports for ACCORD HEALTHCARE INC
Company Name
ACCORD HEALTHCARE INC
Shortage reports
Actual shortage:
90 (25%)
Anticipated shortage:
0 (0%)
Avoided shortage:
2 (1%)
Resolved:
274 (75%)
366
Discontinuation Reports
To be discontinued:
1 (100%)
Discontinued:
0 (0%)
Reversed:
0 (0%)
1
22 (6%)
2 (2%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METHOTREXATE INJECTION BP | 25MG | SOLUTION | Actual shortage | 2024-04-16 | 2025-04-07 | 225235 |
| METHOTREXATE INJECTION BP | 25MG | SOLUTION | Resolved | 2024-03-26 | 2024-11-16 | 223395 |
| METHOTREXATE INJECTION BP | 25MG | SOLUTION | Resolved | 2025-01-08 | 2025-04-13 | 247127 |
| METHOTREXATE INJECTION BP | 25MG | SOLUTION | Resolved | 2024-05-03 | 2024-11-16 | 227108 |
| METHOTREXATE INJECTION BP | 25MG | SOLUTION | Resolved | 2025-01-08 | 2025-04-12 | 247130 |
| METHOTREXATE INJECTION BP | 25MG | SOLUTION | Actual shortage | 2024-02-02 | 2025-03-06 | 218309 |
| METHOTREXATE INJECTION BP | 25MG | SOLUTION | Actual shortage | 2024-05-03 | 2024-07-24 | 227100 |
| METHOTREXATE INJECTION BP | 25MG | SOLUTION | Resolved | 2024-07-19 | 2024-11-15 | 233457 |
| METHOTREXATE INJECTION, BP | 25MG | SOLUTION | Resolved | 2017-03-17 | 2017-04-08 | 3262 |
| METHOTREXATE SUBCUTANEOUS | 17.5MG | SOLUTION | Resolved | 2022-11-25 | 2023-06-30 | 175814 |
| METHOTREXATE SUBCUTANEOUS | 20MG | SOLUTION | Resolved | 2023-01-13 | 2023-01-28 | 181024 |
| METHOTREXATE SUBCUTANEOUS | 20MG | SOLUTION | Resolved | 2023-05-05 | 2023-05-18 | 191746 |
| METHOTREXATE SUBCUTANEOUS | 20MG | SOLUTION | Resolved | 2023-06-12 | 2023-06-17 | 194721 |
| METHOTREXATE SUBCUTANEOUS | 20MG | SOLUTION | Resolved | 2023-07-07 | 2023-07-22 | 197905 |
| METHOTREXATE SUBCUTANEOUS | 20MG | SOLUTION | Resolved | 2023-09-01 | 2023-10-03 | 203459 |
| METHOTREXATE SUBCUTANEOUS | 20MG | SOLUTION | Resolved | 2023-10-20 | 2023-10-27 | 207602 |
| METHOTREXATE SUBCUTANEOUS | 20MG | SOLUTION | Resolved | 2023-11-24 | 2024-01-19 | 211388 |
| METHOTREXATE SUBCUTANEOUS | 20MG | SOLUTION | Resolved | 2024-04-19 | 2024-05-10 | 225687 |
| METHOTREXATE SUBCUTANEOUS | 20MG | SOLUTION | Resolved | 2024-10-18 | 2024-11-01 | 240673 |
| METHOTREXATE SUBCUTANEOUS | 22.5MG | SOLUTION | Resolved | 2023-06-12 | 2023-06-30 | 194718 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | 20MG | SOLUTION | To be discontinued | 2025-11-03 | 2025-11-15 | 257644 |
Showing 1 to 1 of 1